Table 1.
Overall patients | Patients without HCC (n = 1177) | Patients with HCC (n = 1071) | P-value | |
---|---|---|---|---|
Age at listing (years) | 53.5 ± 9.1 | 51.7 ± 9.6 | 55.5 ± 7.9 | <0.001 |
Male, n (%) | 1650 (73.4%) | 823 (69.9%) | 827 (77.2%) | <0.001 |
Blood type, n (%) | 0.971 | |||
A | 776 (34.5%) | 403 (34.2%) | 373 (34.9%) | |
B | 654 (29.1%) | 344 (29.2%) | 310 (28.9%) | |
AB | 250 (11.1%) | 134 (11.4%) | 116 (10.8%) | |
O | 568 (25.3%) | 296 (25.2%) | 272 (25.4%) | |
Body mass index (kg/m2) | 24.1 ± 3.5 | 24.0 ± 3.7 | 24.2 ± 3.3 | 0.12 |
Original liver disease, n (%) | <0.001 | |||
Hepatitis B virus | 1595 (71.0%) | 707 (60.1%) | 888 (82.9%) | |
Hepatitis C virus | 200 (8.9%) | 93 (7.9%) | 107 (10.0%) | |
Alcoholic | 360 (16.0%) | 304 (25.8%) | 56 (5.2%) | |
Cholestatic | 40 (1.8%) | 37 (3.1%) | 3 (0.3%) | |
Others | 53 (2.3%) | 36 (3.1%) | 17 (1.6%) | |
CTP class, n (%) | <0.001 | |||
A | 374 (16.6%) | 79 (6.7%) | 295 (27.5%) | |
B | 938 (41.7%) | 397 (33.7%) | 541 (50.6%) | |
C | 936 (41.7%) | 701 (59.6%) | 235 (21.9%) | |
MELD score | 17.1 ± 8.9 | 20.5 ± 9.2 | 13.4 ± 6.6 | <0.001 |
Status*, n (%) | <0.001 | |||
2A | 159 (7.1%) | 122 (10.4%) | 37 (3.5%) | |
2B | 1395 (62.1%) | 665 (56.5%) | 730 (68.2%) | |
3 | 694 (30.8%) | 390 (33.1%) | 304 (28.3%) |
*Status based on previous Korean liver allocation system.